By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

OK

By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

Gilead Sciences

Gilead and AI-focused Genesis partner to develop small molecule therapies PMLiVE12:42Biotech AI Pharma

Gilead and Genesis partner to create novel therapies using AI Pharmaceutical Technology11:05Biotech AI Pharma

Ex-Dividend reminder: Gilead Sciences, thermo fisher scientific and valley national bancorp Nasdaq17:35Biotech Pharma World Banking

Don't buy Gilead Sciences, Inc. (Nasdaq:GILD) for its next Dividend without doing these checks Simply Wall St19:01Biotech Pharma World Banking

Avenzo and Gilead partner for breast cancer combination regimen trial Clinical Trials Arena11:54Cancer Treatment Pharma Biotech

Latest News

In the last 2 hours

Gilead’s Twice-Yearly Shot Prevents 96% of HIV Cases in Study BNN Bloomberg16:23

In the last 4 hours

OmRx Oncology Launches to Advance Investigational Oral Checkpoint Inhibitor Designed to… Business Wire (Press Release)14:06

In the last 6 hours

Gilead’s Twice-Yearly Lenacapavir for HIV Prevention Reduced HIV Infections by 96% and… Business Wire (Press Release)13:36

Yesterday

Ex-Dividend Reminder: Gilead Sciences, Thermo Fisher Scientific and Valley National Bancorp Nasdaq17:35 11-Sept-24

Gilead and AI-focused Genesis partner to develop small molecule therapies PMLiVE12:42 11-Sept-24

Gilead and Genesis partner to create novel therapies using AI Pharmaceutical Technology11:05 11-Sept-24

In the last 7 days

Gilead Sciences To Work With Genesis To Apply AI Platform To Discover, Advance Therapies RTT News13:20 10-Sept-24

Gilead and Genesis Therapeutics Announce Strategic Collaboration to Discover and Develop Novel… Business Wire (Press Release)13:05 10-Sept-24

Don't Buy Gilead Sciences, Inc. (NASDAQ:GILD) For Its Next Dividend Without Doing These Checks Simply Wall St19:01 8-Sept-24

Is Gilead Sciences Stock Underperforming the Dow? Barchart16:03 5-Sept-24

Gilead to Present New Trodelvy® Data at the IASLC 2024 World Conference on Lung Cancer Business Wire (Press Release)13:00 5-Sept-24

In the last month

Chamber Backs Gilead's Immunity In COVID Appeal Law36023:38 4-Sept-24

Avenzo and Gilead partner for breast cancer combination regimen trial Clinical Trials Arena11:54 4-Sept-24

Merck's Death Cross Vs. Gilead's Golden Cross: Pharma Giants Diverge On Wall Street Benzinga21:23 3-Sept-24

Gilead Sciences Options Trading: A Deep Dive into Market Sentiment Benzinga17:47 3-Sept-24

Avenzo Therapeutics Announces Clinical Study Collaboration with Gilead Sciences to Evaluate… Business Wire (Press Release)14:02 3-Sept-24

Gilead Sciences Might Finally Be On Its Way To Higher Stock Prices Seeking Alpha13:34 2-Sept-24

Gilead Sciences: Buy This Bargain Before It's Gone Seeking Alpha02:58 31-Aug-24

Lawyer Found Way Back to Work One National Park at a Time Bloomberg Law10:07 30-Aug-24

Health ministry approves Truvada as HIV prevention drug The Japan Times10:20 29-Aug-24

Nowacki v. Gilead Sciences U.S. Chamber of Commerce (Press Release)15:38 23-Aug-24

Duty to Innovate Before The California Supreme Court: The Briefs Are In Drug & Device Law06:17 23-Aug-24

ST Pharm lands major API supply deal with Gilead Sciences: sources Korea Biomedical Review07:14 22-Aug-24

Gilead Sciences to Present at Upcoming Investor Conferences Business Wire (Press Release)21:05 21-Aug-24

Gilead's Livdelzi granted accelerated FDA approval for primary biliary cholangitis Outsourcing-Pharma.com16:30 20-Aug-24

PANTHERx Rare and Gilead Sciences partner to distribute Livdelzi Manufacturing Chemist11:47 20-Aug-24

Gilead partners with PANTHERx for LIVDELZI distribution Pharmaceutical Technology11:21 19-Aug-24

FDA Grants Accelerated Approval to Gilead Treatment for Primary Biliary Cholangitis PharmTech.com19:24 16-Aug-24

PANTHERx® Rare Partnering with Gilead Sciences, Inc. for the Distribution of LIVDELZI® PR Newswire (Press Release)16:38 16-Aug-24

Gilead's Ongoing Battle Against Counterfeit HIV Medications Persists With New Lawsuit, Seizes $750K In Fake Drugs Benzinga16:33 16-Aug-24

Gilead must be held accountable for the harm caused by ‘patent hopping’ an HIV treatment STAT09:41 16-Aug-24

Gilead’s PBC therapy Livdelzi bags accelerated approval Pharmaceutical Technology21:15 15-Aug-24

Gilead gains accelerated FDA approval for rare liver disease treatment Biopharma Reporter15:33 15-Aug-24

FDA Approves Gilead's Seladelpar For Inflammatory Liver Disease, Acquired Via $4B CymaBay Deal Benzinga14:18 15-Aug-24

FDA approves drug for primary biliary cholangitis Pharmafile13:25 15-Aug-24

Orsini Now Dispensing Livdelzi (seladelpar), for Treatment of Rare Liver Disease PR Newswire (Press Release)12:06 15-Aug-24

FDA OKs New Option for Primary Biliary Cholangitis Medpage Today07:12 15-Aug-24

Gilead’s Liver Drug Wins FDA Approval, to Cost $12,606 a Month BNN Bloomberg20:24 14-Aug-24

STAT Plus: Gilead wins U.S. approval for drug to treat autoimmune liver disease STAT19:12 14-Aug-24

Gilead’s Livdelzi (Seladelpar) Granted Accelerated Approval for Primary Biliary Cholangitis by… Business Wire (Press Release)19:02 14-Aug-24

view more headlines

12 Sept 16:23

Publication filters

Notifications

Unsubscribe from Breaking News

Sorry, no headlines or news topics were found. Please try different keywords.